Diagnostics
We leverage our core expertise in the molecular mechanisms of different ophthalmic disorders for innovative diagnostic and therapeutic development.
We leverage our core expertise in the molecular mechanisms of different ophthalmic disorders for innovative diagnostic and therapeutic development.
The i-ImmunDx™ Analyzer is Seinda’s proprietary diagnostic platform engineered to deliver high-sensitivity, high-precision results for tear-based biomarker testing—quickly and reliably at the point of care.
Seinda’s Microfluidic Tear Collector is a proprietary, single-use device engineered for fast, comfortable, and Seinda’s Microfluidic Tear Collector is a proprietary, single-use device engineered for fast, comfortable, and contamination-free collection of tear fluid.
Seinda’s series of point-of-care testing solutions:
– Dry eye (LTA-POC Test)
– Allergy (IgE-POC Test)
– Ocular Inflammation (MMP9-POC Test)
– IL6-POC Test and IL8-POC Test (Launching in 2026)